news Highly potent antiviral against dengue could prevent spread of virus 18 October 2021 | By Victoria Rees (Drug Target Review) A new antiviral has shown promise against the dengue virus in mice and has the potential to be used as a preventative measure.
news Mosquito protein could hold key to therapeutics against flaviviruses 11 March 2021 | By Victoria Rees (Drug Target Review) A study has shown the mosquito protein AEG12 inhibits flaviviruses, the family of viruses that cause yellow fever, dengue and Zika.
news 2B7 antibody could be the breakthrough needed for dengue fever therapies 8 January 2021 | By Hannah Balfour (Drug Target Review) Scientists show that an antibody targeting a protein acting as a viral toxin, can prevent the dengue virus from infecting human cells.
news NIAID unveils new Centers for Research in Emerging Infectious Diseases (CREID) 2 September 2020 | By Hannah Balfour (Drug Target Review) The global network of centers will investigate where pathogens emerge and how they adapt to cause disease in humans, in the hopes of increasing our preparedness for future disease outbreaks.
news £280 million donated for COVID-19 research in three months 21 April 2020 | By Victoria Rees (Drug Target Review) A study has shown that the COVID-19 pandemic has resulted in a high level of research donations, making the condition the third most funded disease on average by year.
news Disrupting serotonin receptors to control spread of dengue and Zika 18 October 2018 | By Drug Target Review Researchers are developing methos to decrease the body size and weight of mosquitoes in order to control the spread of dengue and Zika...
news Scientists identify antibodies that can neutralise Zika and dengue 24 June 2016 | By Victoria White, Digital Content Producer Scientists have identified antibodies that can efficiently neutralise both the dengue virus and the Zika virus...